Reports
-
Untangling the Web of antiretroviral price reductions - Upcoming 12th Edition Pre-publication price analysis July 2009
The 12th edition of ‘Untangling the Web’, Médecins Sans Frontières’ annual analysis of antiretroviral (ARV) price reductions is upcoming. This paper serves as a pre-publication price analysis,...
Last updated 18 July 2009
www.msfaccess.org/our-work/addressing-medical-challenges/article/902 -
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun
Over three million people living with HIV/AIDS in the developing world receive antiretroviral therapy (ART). However, the medicines and diagnostic tools available are inadequate to respond fully to their...
Last updated 19 July 2009
www.msfaccess.org/our-work/addressing-medical-challenges/article/901 -
PLoS:Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease.
MSF has provided diagnostic and treatment services for Chagas disease since 1999. This report describes 10 years of field experience in four MSF programmes in Honduras, Guatemala, and Bolivia, focusing...
Last updated 9 July 2009
www.msfaccess.org/our-work/addressing-medical-challenges/article/903 -
Untangling the Web of Antiretroviral Price Reductions 6th Edition
The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear and verified data....
Last updated 1 April 2004
www.msfaccess.org/our-work/addressing-medical-challenges/article/940 -
Untangling the Web of Antiretroviral Price Reductions 7th Edition
The aim of this document is to provide information on pricing and suppliers that will help purchasers make informed decisions when buying ARVs.
Last updated 1 January 2005
www.msfaccess.org/our-work/addressing-medical-challenges/article/936 -
Untangling the Web of Antiretroviral Price Reductions 8th Edition
The purpose of this document is to provide information on prices and suppliers that will help purchasers make informed decisions when buying ARVs.
Last updated 5 September 2006
www.msfaccess.org/our-work/addressing-medical-challenges/article/930 -
TB background document: New Faces of an Old Disease
Many people in rich countries think of tuberculosis as a disease of the past. Indeed well into the 1980s, experts thought that tuberculosis (TB) could be eliminated in a matter of decades. TB was seemingly...
Last updated 24 March 2009
www.msfaccess.org/our-work/addressing-medical-challenges/article/904 -
Cough Up For TB! The Underfunding of Research for Tuberculosis and Other Neglected Diseases by Germany
In their work in field projects, MSF staff can only do so much, they frequently lack sufficient treatment possibilities to address diseases that primarily affect people in developing countries. Because...
Last updated 22 April 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/913 -
Cough Up For TB! The Underfunding of Research for Tuberculosis and Other Neglected Diseases by the European Commission
Executive SummaryNeglected diseases, neglected patients Médecins Sans Frontières (MSF) teams are faced every day with the lack of adequate or effective tools needed to treat, detect or prevent disease....
Last updated 12 November 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/906 -
Untangling the Web of Antiretroviral Price Reductions 11th Edition
The purpose of this document is to provide information on prices and suppliers that will help purchasers make informed decisions when buying ARVs. However, it is of course important to not only consider...
Last updated 15 July 2008
www.msfaccess.org/our-work/addressing-medical-challenges/article/911
